First triMS.online conference

Hot topics in
multiple sclerosis

First triMS.online conference, November 2018

  • The latest research and clinical insights on the theme Progressive MS: is PPMS modifiable?
  • A ‘hot topic’ debate on the motion ‘We should routinely monitor cognition in standard MS clinical practice’

NovartisRoche

About this event

The first of our pioneering triMS.online global conferences took place on 27 November 2018 and showcased the latest developments in progressive MS. It was titled Progressive MS: is PPMS modifiable? The launch of triMS.online provided an exciting and diverse mix of presentations and engaging discussion on the ‘hot topic’ debate on the motion ‘We should routinely monitor cognition in standard MS clinical practice’. This truly global event brought together almost 400 delegates, enabling everyone to interact, network and share their thoughts. Participants may not have otherwise had the opportunity to do this without our unique platform! The conference was such a success, we realised we were at the beginning of a very exciting future and had created a truly inclusive event!

free-registration

Video

Chapters

00:00:00 Opening remarks
Gavin Giovannoni, UK
00:05:38 When does progressive MS begin?
Shibeshih Belachew, Switzerland
00:15:34 Redefining secondary progressive MS: the case for metrics
Tomas Kalincik, Australia
00:27:04 Upper limb function as a primary outcome measure in progressive MS clinical trials
Maria Pia Sormani, Italy
00:35:00 The visual system as a window into the study of progressive MS
Ari Green, USA
00:43:57 Spinal cord imaging in progressive MS: current and future prospects
Carmen Tur, UK
00:53:05 Cerebrospinal fluid biomarkers in progressive MS trials
Sharmilee Gnanapavan, UK
01:05:00 The pathogenesis of progressive MS: making the case for one, two or three diseases?
Bruce Trapp, USA
01:15:33 Company-sponsored satellite F. Hoffmann-La Roche: Is chronic inflammation present from the inception of MS? Insights from pathology and imaging
Assunta Dal-Bianco, Austria
01:31:52 Company-sponsored satellite Novartis Pharma AG: Looking at the opposite side of the disease continuum: Acting early – new evidence in the treatment of paediatric-onset MS
Brenda Banwell, USA
01:48:01 Break
02:14:56 Hot topic debate: cognition in MS Motion: ‘We should routinely monitor cognition in standard MS clinical practice’ -
For: James Sumowski, USA
Against: Anneke Van Der Walt, Australia
Seconders, For: Dawn Langdon, UK
02:47:45 Moderated discussion and Q&A
Panel
02:56:42 Final summing up and close
Gavin Giovannoni, UK

Scientific programme

14:00

Opening remarks

Gavin Giovannoni, UK

Progressive MS: is it modifiable?

14:05

Keynote presentation

When does progressive MS begin?

Shibeshih Belachew, Switzerland

14:15

Redefining secondary progressive MS: the case for metrics

Tomas Kalincik, Australia

Upper limb function as a primary outcome measure in progressive MS clinical trials

Maria Pia Sormani, Italy

The visual system as a window into the study of progressive MS

Ari Green, USA

Spinal cord imaging in progressive MS: current and future prospects

Carmen Tur, UK

Cerebrospinal fluid biomarkers in progressive MS trials

Sharmilee Gnanapavan, UK

15:05

Keynote presentation

The pathogenesis of progressive MS:making the case for one, two or three diseases?

Bruce Trapp, USA

Company-sponsored satellites
15:15

F. Hoffmann-La Roche
Is chronic inflammation present from the inception of MS? Insights from pathology and imaging

Assunta Dal-Bianco, Austria

15:35

Novartis Pharma AG
Looking at the opposite side of the disease continuum: Acting early – new evidence in the treatment of
paediatric-onset MS

Brenda Banwell, USA

Exhibitions
15:55

Free time to explore exhibit hall

Hot topic debate: cognition in MS

16:15

Motion: ‘We should routinely monitor cognition in standard MS clinical practice’

Chair’s introduction and audience vote on the motion

Gavin Giovannoni

Keynote presentations

For: James Sumowski, USA
Against: Anneke Van Der Walt, Australia

Seconders

For: Dawn Langdon, UK
Against: Jiwon Oh, Canada

Moderated discussion and Q&A
16:55

Final summing up and close

Resources

Hot topics in multiple sclerosis

0.17MB PDF

Speaker biographies

0.45MB PDF

Thank you so much for all the thinking and awareness-raising you do for MS research; it is impressive and invaluable. Please do not stop.

Delegate feedback

Thank you. This meeting was eco-friendly and allowed me to get out of it what I needed.

Delegate feedback

It was a well balanced and comprehensive package in my view, between live and static assets

Delegate feedback